We are live on ! Find out more
CTIC

CTI BioPharma Corp. (DE) Common Stock
CTIC

Delisted

CTIC was delisted on the 23rd of June, 2023.

Back to rankings

67 hedge funds and large institutions have $52M invested in CTI BioPharma Corp. (DE) Common Stock in 2013 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more capital invested

Capital invested by funds: $25.9M → $52M (+$26M)

56% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 16

38% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 13

5% more funds holding

Funds holding: 64 → 67 (+3)

98% less call options, than puts

Call options by funds: $6K | Put options by funds: $282K

Holders
67
Holders Change
+3
Holders Change %
+4.69%
% of All Funds
2.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
25
Reduced
16
Closed
13
Calls
$6K
Puts
$282K
Net Calls
-$276K
Net Calls Change
-$91K

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$8.1M
2
Northern Trust
Northern Trust
Illinois
+$1.15M
3
State Street
State Street
Massachusetts
+$1.04M
4
BFA
BlackRock Fund Advisors
California
+$427K
5
CS
Credit Suisse
Switzerland
+$375K

Top Sellers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$782K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$612K
3
Morgan Stanley
Morgan Stanley
New York
-$300K
4
Bank of America
Bank of America
North Carolina
-$166K
5
Jane Street
Jane Street
New York
-$150K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFEC
51
Benjamin F. Edwards & Company
Missouri
$18K +$12.6K +1,090 New
Comerica Bank
52
Comerica Bank
Texas
$18K +$12.7K +1,096 New
Citadel Advisors
53
Citadel Advisors
Florida
$18K +$12.8K +1,103 New
Nomura Holdings
54
Nomura Holdings
Japan
$17K -$44.8K -3,870 -78%
Creative Planning
55
Creative Planning
Kansas
$17K -$4.58K -395 -27%
SB
56
Suntrust Banks
Georgia
$16K +$11.6K +1,000 New
Commonwealth Equity Services
57
Commonwealth Equity Services
Massachusetts
$16K +$11.7K +1,011 New
Schroder Investment Management Group
58
Schroder Investment Management Group
United Kingdom
$12.2K +$8.69K +750 New
Ameriprise
59
Ameriprise
Minnesota
$12K – – –
RFC
60
Russell Frank Company
Washington
$5K +$707 +61 +26%
BlackRock
61
BlackRock
New York
$4K +$2.96K +255 New
LTFS
62
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Royal Bank of Canada
63
Royal Bank of Canada
Ontario, Canada
$1K +$695 +60 New
FWM
64
Focused Wealth Management
New York
$1K +$1.03K +89 New
Manulife (Manufacturers Life Insurance)
65
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$163 +$1.3K +112 +1%
CAS
66
CTC Alternative Strategies
Illinois
– -$113K -10,730 Closed
DMAM
67
Del Mar Asset Management
New York
– -$100K -9,597 Closed
APU
68
Alpine Partners USVI
U.S. Virgin Islands
– -$94K -9,002 Closed
VF
69
Virtu Financial
New York
– -$91K -8,700 Closed
Two Sigma Advisers
70
Two Sigma Advisers
New York
– -$65K -6,223 Closed
OAM
71
Oxford Asset Management
United Kingdom
– -$36K -3,384 Closed
ST
72
Spot Trading
Illinois
– -$18K -1,735 Closed
NCCM
73
Nine Chapters Capital Management
New Jersey
– -$18K -1,730 Closed
Millennium Management
74
Millennium Management
New York
– -$17K -1,635 Closed
JG
75
Jefferies Group
New York
– -$12K -1,147 Closed
1 2
3
4

CTIC Hedge Fund Activity: Q3 2013 in Review

67 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in CTI BioPharma Corp. (DE) Common Stock (CTIC) for Q3 2013, worth a combined $52M — up 100% from $25.9M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new CTIC positions and 13 closed out — a net gain of 5 holders — while 25 added to existing stakes and 16 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $8.1M. The largest seller was Jacobs Levy Equity Management, cutting an estimated $782K.

  • 67 institutional investors held CTI BioPharma Corp. (DE) Common Stock (CTIC) as of Q3 2013, up from 64 in Q2 2013.
  • Funds reported $52M of CTI BioPharma Corp. (DE) Common Stock stock for Q3 2013, up 100% quarter-over-quarter.
  • 18 funds opened new CTI BioPharma Corp. (DE) Common Stock positions in Q3 2013 and 13 closed out, a net change of +5 holders.
  • The largest CTI BioPharma Corp. (DE) Common Stock buyer in Q3 2013 was Perceptive Advisors, an estimated $8.1M added.
  • The largest CTI BioPharma Corp. (DE) Common Stock seller in Q3 2013 was Jacobs Levy Equity Management, an estimated $782K sold.

Based on aggregated 13F filings for Q3 2013.